Charles River Laboratories InternationalvsEli Lilly and Company

CRL and LLY stock compared: price, dividend, valuation and results, from SEC filings.

CRL

Charles River Laboratories International, Inc.

$333.25

Value $16.4B

+0.33%
CRL's page

LLY

Eli Lilly and Company

$1,382.75

Value $1.30T

-2.32%
LLY's page

Charles River Laboratories International (CRL) has a market value of $16.4B and Eli Lilly and Company (LLY) $1.30T. Over the last year, with dividends, CRL moved +104.8% and LLY +36.2%. Dividend yield: CRL none, LLY 0.46%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CRL$16.4B

    LLY$1.30T

    LLY is 80 times CRL

  • Revenue, 12 months

    CRL$4.0B

    LLY$86.5B

    LLY is 22 times CRL

  • Net income, 12 months

    CRL$40M

    LLY$27.6B

    LLY is 686 times CRL

  • Operating margin

    CRL4.0%

    LLY–

  • ROIC

    CRL2.3%

    LLY35.5%

    33.2 points apart

  • P/E

    CRL–

    LLY47.3

  • Dividend yield

    CRL0.0%

    LLY0.5%

    0.5 points apart

  • 5-year return

    CRL-15.2%

    LLY+452.8%

    468.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CRL-15.2%

LLY+452.8%

020040060020222023202420252026
Returns by period
PeriodCRLWith dividendsLLYWith dividends
1 year since November 17, 2025+104.8%Price +104.8%+36.2%Price +35.3%
3 years since November 17, 2023+76.3%+20.8% a yearPrice +76.3%+138.4%+33.6% a yearPrice +133.7%
5 years since November 17, 2021-15.2%-3.2% a yearPrice -15.2%+452.8%+40.8% a yearPrice +429.4%
10 years since November 21, 2016+360.0%+16.5% a yearPrice +360.0%+1,998.7%+35.6% a yearPrice +1,704.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CRLCharles River Laboratories InternationalLLYEli Lilly and Company

Valuation

CRLLLY
Valuation
Price$333.25$1,382.75
Market value$16.4B$1.30T
Enterprise value (EV)$18.7B$1.35T
P/E–47.3
P/E, 5-year median25.649.9
P/B5.132.4
EV/EBIT117.338.8
Free cash flow yield2.4%1.5%

Results and growth

CRLLLY
Results and growth
Revenue, 12 months$4.0B$86.5B
Net income, 12 months$40M$27.6B
Free cash flow, 12 months$400M$19.7B
Earnings per share, 12 months$0.97$30.81
Revenue growth, year on year-0.9%44.7%
Revenue growth a year, past+6.6%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

CRLLLY
Margins and returns on capital
Gross margin–83.6%
Operating margin4.0%–
Net margin1.0%31.9%
ROIC2.3%35.5%
ROE1.3%88.6%

Balance sheet

CRLLLY
Balance sheet
Cash$200M$4.9B
Total debt$2.9B$49.5B
Net debt / EBITDA4.01.2
Interest cover1.5×38.9×

Dividends and buybacks

CRLLLY
Dividends and buybacks
Dividend yield–0.5%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield2.2%0.3%
Shareholder yield2.2%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CRL or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Charles River Laboratories International or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.30T) is about 79.5 times Charles River Laboratories International ($16.4B), at today's prices.

How did CRL and LLY stock do over the last 10 years?

Since November 21, 2016, CRL's price moved +360.0% and LLY's +1,704.2%. With dividends: CRL +360.0% (+16.5% a year), LLY +1,998.7% (+35.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, CRL or LLY?

The dividend yield at today's price is none for Charles River Laboratories International and 0.46% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

Which has the higher profit margins, Charles River Laboratories International or Eli Lilly and Company?

Over the last twelve months, the net margin was 1.0% for Charles River Laboratories International and 31.9% for Eli Lilly and Company, and the operating margin 4.0% and –. Revenue was $4.0B and $86.5B.

Which is the better investment, Charles River Laboratories International or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.